Saxenda Prescription in Sherman, Texas at DFWPMA

Looking for a Saxenda prescription in Sherman, Texas? Saxenda (liraglutide) is a prescription GLP-1 medication used for chronic weight management. It requires careful medical evaluation because inappropriate prescribing or inadequate monitoring can lead to serious health complications.

At DFW Physicians Medical Associates (DFWPMA), our endocrinology and primary care providers conduct comprehensive evaluations of weight-related health conditions, metabolic health, medical history, and treatment risks to determine whether Saxenda is safe and appropriate for each patient.

DFWPMA offers Saxenda prescription evaluations in Sherman and can prescribe Saxenda to eligible patients when medically appropriate. Saxenda is FDA-approved for chronic weight management in qualifying adults and adolescents aged 12 years and older who meet specific weight-related eligibility criteria.

Book an appointment online or call (903) 957-0082 to contact our Sherman location.
Address: 📍
425 N Highland Ave., Suite 260, Sherman, TX 75092

Click here to get directions

We accept many major insurance plans. Not sure if your plan is accepted?

Call (903) 957-0082 and our team can help verify coverage.

Why Choose DFWPMA for a Saxenda Prescription in Sherman, Texas?

DFW Physicians Medical Associates provides Saxenda prescription evaluations in Sherman through medical providers experienced in endocrinology, metabolic health, weight management, and chronic disease treatment. Our multispecialty approach supports individualized medical assessments, responsible prescribing decisions, and ongoing supervision.

Patients seeking a Saxenda prescription at DFWPMA can benefit from:

  • Experienced Medical Providers: Access to endocrinology and primary care providers experienced in metabolic health, diabetes care, and chronic disease management.
  • Comprehensive Eligibility Assessment: Reviewing body mass index (BMI), weight-related medical conditions, treatment history, and potential contraindications before prescribing Saxenda.
  • Weight and Metabolic Health Evaluation: Assessing obesity, blood glucose, blood pressure, cholesterol, and other metabolic indicators when clinically appropriate.
  • Individualized Prescription Decisions: Developing treatment recommendations according to medical eligibility, weight-management goals, clinical risks, and overall health.
  • Medication Safety Screening: Evaluating contraindications and precautions involving thyroid cancer history, pancreatitis, gastrointestinal disorders, gallbladder disease, and other relevant conditions.
  • Dosage Management and Monitoring: Adjusting medication doses gradually and monitoring treatment tolerance, clinical response, and potential adverse effects.
  • Long-Term Weight Management: Monitoring weight changes, metabolic health, treatment effectiveness, and sustainable lifestyle modifications.
  • Coordinated Multispecialty Care: Connecting patients with additional medical and behavioral health services when comprehensive weight-related support is needed.

Saxenda is not appropriate for every patient seeking weight loss. Prescribing decisions require evaluating obesity-related health risks, potential adverse effects, medication contraindications, and alternative treatment options.

At DFWPMA Sherman, comprehensive medical evaluations and individualized treatment planning are central to determining whether Saxenda is an appropriate weight-management medication.

Schedule an appointment with DFWPMA Sherman to discuss Saxenda prescription eligibility and your weight-management options.

Meet Our Saxenda Prescription Providers in Sherman, Texas

DFWPMA Sherman offers Saxenda prescription evaluations through endocrinology and primary care providers experienced in weight management, metabolic disorders, diabetes care, and chronic disease treatment. These providers can assess medical eligibility and determine whether Saxenda is appropriate.

Gitana Staskus, MD – Endocrinology

Dr. Gitana Staskus is a board-certified endocrinologist with more than 20 years of clinical experience diagnosing and treating endocrine and metabolic disorders in adults and older adults.

Her expertise includes weight management, metabolic disorders, type 1 and type 2 diabetes, thyroid conditions, hormone disorders, and osteoporosis. Dr. Staskus emphasizes individualized treatment planning, patient education, and long-term management of endocrine conditions.

Her specialized background in weight management and metabolic health is particularly relevant for patients seeking Saxenda prescription evaluations, including individuals with obesity and related metabolic conditions.

Aniwelyn Tan, DNP – Primary Care

Aniwelyn Tan is an experienced primary care provider with more than 20 years of healthcare experience, including extensive work with chronic medical conditions and cardiovascular health.

Her clinical expertise includes obesity, weight management, diabetes, hypertension, internal medicine, and chronic disease treatment. She provides primary care services for patients ages 15 and older.

Her experience addressing obesity and metabolic conditions supports Saxenda prescription evaluations, including weight-related health assessments, medication safety reviews, and individualized treatment monitoring.

Ayodya Perera, MD – Family Medicine

Dr. Ayodya Perera is a family medicine physician providing preventive healthcare, comprehensive primary care, and chronic disease management for patients ages 15 and older.

Dr. Perera’s clinical interests include weight management, diabetes treatment, hypertension, preventive medicine, and patient-centered medical care. The physician emphasizes individualized treatment recommendations and shared decision-making.

This background in weight management and chronic disease care is relevant to Saxenda prescription evaluations, including assessing obesity-related health concerns, reviewing medical eligibility, and developing long-term treatment plans.

Book an appointment online to inquire about Saxenda prescription evaluations with DFWPMA’s medical providers in Sherman.

What Can a Saxenda Prescription in Sherman, Texas Help With?

Saxenda (liraglutide) is a once-daily injectable GLP-1 receptor agonist approved for chronic weight management in eligible adults and adolescents aged 12 years and older. It helps regulate appetite, reduce calorie intake, and support weight loss alongside dietary changes and physical activity.

At DFWPMA Sherman, Saxenda prescription evaluations address:

  • Obesity Treatment: Supporting chronic weight management in adults with a BMI of 30 or higher.
  • Overweight With Related Health Conditions: Treating eligible adults with a BMI of 27 or higher and a weight-related medical condition.
  • Chronic Weight Management: Supporting clinically meaningful weight loss and long-term weight maintenance.
  • Appetite Regulation: Reducing hunger and food intake through GLP-1 receptor activation.
  • Weight-Related Metabolic Conditions: Supporting weight management in eligible patients with hypertension, high cholesterol, or type 2 diabetes.
  • Adolescent Obesity: Supporting weight management in eligible adolescents aged 12 years and older who meet age-specific criteria.
  • Weight Management After Previous Treatment: Evaluating Saxenda when lifestyle interventions or previous weight-management treatments have produced insufficient results.

Saxenda activates GLP-1 receptors involved in appetite regulation, helping patients feel fuller and consume fewer calories. Unlike weekly GLP-1 medications, Saxenda requires a daily injection.

The American College of Physicians recognizes GLP-1 receptor agonists as pharmacologic options for eligible adults with obesity or overweight and associated medical conditions.

Source: American College of Physicians – Pharmacologic Treatments for Overweight and Obesity

Saxenda is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or MEN2. Important risks include pancreatitis, gallbladder disease, severe gastrointestinal reactions, dehydration-related kidney injury, and increased heart rate.

Saxenda and Victoza contain the same active ingredient, liraglutide, but have different approved indications. Saxenda is specifically approved for chronic weight management, while Victoza is prescribed for type 2 diabetes and certain cardiovascular risk-reduction indications.

Schedule an appointment to discuss Saxenda prescription eligibility at DFWPMA Sherman.

What Saxenda Prescription Services Are Available at DFWPMA Sherman?

DFWPMA Sherman provides Saxenda prescription evaluations, weight and metabolic health assessments, medication safety reviews, treatment planning, and ongoing monitoring through endocrinology and primary care providers.

Our Saxenda prescription services include:

  • Initial Saxenda Prescription Evaluation: Reviewing BMI, medical history, weight-related conditions, and treatment eligibility.
  • Weight and Metabolic Health Testing: Assessing weight, blood glucose, cholesterol, and relevant metabolic markers.
  • Medication and Contraindication Review: Identifying medication interactions, contraindications, and potential health risks.
  • Saxenda Prescription and Treatment Planning: Prescribing Saxenda when medically appropriate and establishing weight-management goals.
  • Starting Dose and Titration: Adjusting dosage according to prescribing guidance, treatment response, and tolerance.
  • Side Effect Monitoring: Assessing gastrointestinal symptoms, dehydration, and other adverse reactions.
  • Weight Loss and Treatment Response Monitoring: Tracking weight changes, medication effectiveness, and treatment progress.
  • Long-Term Weight and Metabolic Care: Managing obesity-related health conditions and supporting sustained weight management.
  • Alternative Weight Loss Medication Evaluation: Considering other approved medications when Saxenda is unsuitable.
  • Follow-Up and Coordinated Care: Providing continued medical supervision and specialty referrals when needed.

Saxenda typically starts at 0.6 mg once daily, increasing weekly to the recommended adult maintenance dose of 3 mg daily as tolerated. In adults, treatment should be discontinued if at least 4% weight loss has not occurred after 16 weeks.

Common side effects include nausea, vomiting, diarrhea, constipation, and abdominal discomfort. Severe abdominal pain, significant dehydration, or allergic reactions require prompt medical attention.

The American College of Physicians emphasizes individualized weight-management decisions that consider medication benefits, risks, costs, medical conditions, and long-term health goals.

Source: American College of Physicians – Pharmacologic Treatments for Overweight and Obesity

Not every patient qualifies for Saxenda. A medical evaluation determines whether the medication or an alternative treatment is appropriate. Saxenda should be discontinued if pregnancy occurs.

Looking for a Saxenda prescription in Sherman, Texas? Book an appointment or call (903) 957-0082 to schedule your evaluation at DFWPMA.